Bjornsson E - Search Results

1

Case definition and phenotype standardization in drug-induced liver injury.

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Aithal GP, et al. Among authors: bjornsson e. Clin Pharmacol Ther. 2011 Jun;89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4. Clin Pharmacol Ther. 2011. PMID: 21544079 Review.

2

Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.

De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. De Valle MB, et al. Among authors: bjornsson e. Aliment Pharmacol Ther. 2006 Oct 15;24(8):1187-95. doi: 10.1111/j.1365-2036.2006.03117.x. Aliment Pharmacol Ther. 2006. PMID: 17014577 Free article.

3

The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury.

Björnsson E, Kalaitzakis E, Olsson R. Björnsson E, et al. Aliment Pharmacol Ther. 2007 Jun 15;25(12):1411-21. doi: 10.1111/j.1365-2036.2007.03330.x. Aliment Pharmacol Ther. 2007. PMID: 17539980 Free article.

4

Long-term follow-up of patients with mild to moderate drug-induced liver injury.

Björnsson E, Kalaitzakis E, Av Klinteberg V, Alem N, Olsson R. Björnsson E, et al. Aliment Pharmacol Ther. 2007 Jul 1;26(1):79-85. doi: 10.1111/j.1365-2036.2007.03355.x. Aliment Pharmacol Ther. 2007. PMID: 17555424 Free article.

5

Review article: drug-induced liver injury in clinical practice.

Björnsson E. Björnsson E. Aliment Pharmacol Ther. 2010 Jul;32(1):3-13. doi: 10.1111/j.1365-2036.2010.04320.x. Epub 2010 Mar 31. Aliment Pharmacol Ther. 2010. PMID: 20374223 Free article. Review.

6

Hepatitis E masquerading as drug-induced liver injury.

Chen EY, Baum K, Collins W, Löve A, Merz M, Olafsson S, Björnsson ES, Lee WM. Chen EY, et al. Hepatology. 2012 Dec;56(6):2420-3. doi: 10.1002/hep.26158. Hepatology. 2012. PMID: 23175167

7

Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials.

Avigan MI, Bjornsson ES, Pasanen M, Cooper C, Andrade RJ, Watkins PB, Lewis JH, Merz M. Avigan MI, et al. Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S19-31. doi: 10.1007/s40264-014-0183-6. Drug Saf. 2014. PMID: 25352325 Free PMC article. Review.

8

Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.

Björnsson ES, Hoofnagle JH. Björnsson ES, et al. Hepatology. 2016 Feb;63(2):590-603. doi: 10.1002/hep.28323. Epub 2015 Dec 21. Hepatology. 2016. PMID: 26517184 Review.

9

HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.

Nicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, Bjornsson ES, Cascorbi I, Floratos A, Stammschulte T, Gundert-Remy U, Nelson MR, Aithal GP, Daly AK; International Drug-induced Liver Injury Consortium. Nicoletti P, et al. Pharmacogenet Genomics. 2016 May;26(5):218-24. doi: 10.1097/FPC.0000000000000209. Pharmacogenet Genomics. 2016. PMID: 26959717

10

Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.

Björnsson ES, Gu J, Kleiner DE, Chalasani N, Hayashi PH, Hoofnagle JH; DILIN Investigators. Björnsson ES, et al. J Clin Gastroenterol. 2017 Jan;51(1):63-69. doi: 10.1097/MCG.0000000000000568. J Clin Gastroenterol. 2017. PMID: 27648552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

495 results

Search Page